Timeliness of Transthyretin Cardiac Amyloidosis Diagnosis in the Medicare Population

By afschroeder • April 30, 2026

Spencer-Bonilla G, Fan J, Cheng P, Din N, Rodriguez F, Davies M, Papas MA, Huang J, Venditto J, Witteles RM, Heidenreich P, Alexander K, Sandhu AT. Timeliness of Transthyretin Cardiac Amyloidosis Diagnosis in the Medicare Population. JAMA Cardiol. 2026 Apr 29:e260833. doi: 10.1001/jamacardio.2026.0833. Epub ahead of print. PMID: 42054052; PMCID: PMC13130067.

Tags: Cardiology/Epi, Publications, Veterans Administration

Related Posts

Timeliness of Emergency Care for Intracerebral Hemorrhage Compared With Acute Ischemic Stroke

Royan R, Ikeaba U, Alhanti B, Stamm B, Mac Grory B, Prabhakaran S, Maas MB, Fonarow GC, Messe SR, Mamer LE, Goldstein JN, Saver JL,[...]

Genetically engineering mast cells as effectors for targeted cancer cell cytotoxicity

Han X, Wen D, Fu R, Soto J, Song Y, Wu Y, Wang Z, Lin X, Yu J, Sheng T, Li S, Gu Z, He[...]

Design of Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT-Echo-AI)

Eusuff S, Kim J, Fatima Z, Yalcinkaya D, Sahashi Y, Sandhu A, Nguyen LH, Ambrosy AP, Cheng PP, Chang ST, Go AS, Ahmad FS, Cheung[...]